Cargando…

Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate

BACKGROUND: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease in the Western world. Early and accurate identification of DKD offers the best chance of slowing the progression of kidney disease. An important method for evaluating risk of progressive DKD is abnormal albumin...

Descripción completa

Detalles Bibliográficos
Autores principales: Leong, Amanda, Ekinci, Elif Ilhan, Nguyen, Cattram, Milne, Michele, Hachem, Mariam, Dobson, Matthew, MacIsaac, Richard J., Jerums, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717840/
https://www.ncbi.nlm.nih.gov/pubmed/29207965
http://dx.doi.org/10.1186/s12882-017-0767-3
_version_ 1783284221648830464
author Leong, Amanda
Ekinci, Elif Ilhan
Nguyen, Cattram
Milne, Michele
Hachem, Mariam
Dobson, Matthew
MacIsaac, Richard J.
Jerums, George
author_facet Leong, Amanda
Ekinci, Elif Ilhan
Nguyen, Cattram
Milne, Michele
Hachem, Mariam
Dobson, Matthew
MacIsaac, Richard J.
Jerums, George
author_sort Leong, Amanda
collection PubMed
description BACKGROUND: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease in the Western world. Early and accurate identification of DKD offers the best chance of slowing the progression of kidney disease. An important method for evaluating risk of progressive DKD is abnormal albumin excretion rate (AER). Due to the high variability in AER, most guidelines recommend the use of more than or equal to two out of three AER measurements within a 3- to 6-month period to categorise AER. There are recognised limitations of using AER as a marker of DKD because one quarter of patients with type 2 diabetes may develop kidney disease without an increase in albuminuria and spontaneous regression of albuminuria occurs frequently. Nevertheless, it is important to investigate the long-term intra-individual variability of AER in participants with type 2 diabetes. METHODS: Consecutive AER measurements (median 19 per subject) were performed in 497 participants with type 2 diabetes from 1999 to 2012 (mean follow-up 7.9 ± 3 years). Baseline clinical characteristics were collected to determine associations with AER variability. Participants were categorised as having normo-, micro- or macroalbuminuria according to their initial three AER measurements. Participants were then categorised into four patterns of AER trajectories: persistent, intermittent, progressing and regressing. Coefficients of variation were used to measure intra-individual AER variability. RESULTS: The median coefficient of variation of AER was 53.3%, 76.0% and 67.0% for subjects with normo-, micro- or macroalbuminuria at baseline. The coefficient of variation of AER was 37.7%, 66% and 94.8% for subjects with persistent, intermittent and progressing normoalbuminuria; 43%, 70.6%, 86.1% and 82.3% for subjects with persistent, intermittent, progressing and regressing microalbuminuria; and 55.2%, 67% and 82.4% for subjects with persistent, intermittent and regressing macroalbuminuria, respectively. CONCLUSION: High long-term variability of AER suggests that two out of three AER measurements may not always be adequate for the optimal categorisation and prediction of AER.
format Online
Article
Text
id pubmed-5717840
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57178402017-12-08 Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate Leong, Amanda Ekinci, Elif Ilhan Nguyen, Cattram Milne, Michele Hachem, Mariam Dobson, Matthew MacIsaac, Richard J. Jerums, George BMC Nephrol Research Article BACKGROUND: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease in the Western world. Early and accurate identification of DKD offers the best chance of slowing the progression of kidney disease. An important method for evaluating risk of progressive DKD is abnormal albumin excretion rate (AER). Due to the high variability in AER, most guidelines recommend the use of more than or equal to two out of three AER measurements within a 3- to 6-month period to categorise AER. There are recognised limitations of using AER as a marker of DKD because one quarter of patients with type 2 diabetes may develop kidney disease without an increase in albuminuria and spontaneous regression of albuminuria occurs frequently. Nevertheless, it is important to investigate the long-term intra-individual variability of AER in participants with type 2 diabetes. METHODS: Consecutive AER measurements (median 19 per subject) were performed in 497 participants with type 2 diabetes from 1999 to 2012 (mean follow-up 7.9 ± 3 years). Baseline clinical characteristics were collected to determine associations with AER variability. Participants were categorised as having normo-, micro- or macroalbuminuria according to their initial three AER measurements. Participants were then categorised into four patterns of AER trajectories: persistent, intermittent, progressing and regressing. Coefficients of variation were used to measure intra-individual AER variability. RESULTS: The median coefficient of variation of AER was 53.3%, 76.0% and 67.0% for subjects with normo-, micro- or macroalbuminuria at baseline. The coefficient of variation of AER was 37.7%, 66% and 94.8% for subjects with persistent, intermittent and progressing normoalbuminuria; 43%, 70.6%, 86.1% and 82.3% for subjects with persistent, intermittent, progressing and regressing microalbuminuria; and 55.2%, 67% and 82.4% for subjects with persistent, intermittent and regressing macroalbuminuria, respectively. CONCLUSION: High long-term variability of AER suggests that two out of three AER measurements may not always be adequate for the optimal categorisation and prediction of AER. BioMed Central 2017-12-06 /pmc/articles/PMC5717840/ /pubmed/29207965 http://dx.doi.org/10.1186/s12882-017-0767-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Leong, Amanda
Ekinci, Elif Ilhan
Nguyen, Cattram
Milne, Michele
Hachem, Mariam
Dobson, Matthew
MacIsaac, Richard J.
Jerums, George
Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
title Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
title_full Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
title_fullStr Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
title_full_unstemmed Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
title_short Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
title_sort long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717840/
https://www.ncbi.nlm.nih.gov/pubmed/29207965
http://dx.doi.org/10.1186/s12882-017-0767-3
work_keys_str_mv AT leongamanda longtermintraindividualvariabilityofalbuminuriaintype2diabetesmellitusimplicationsforcategorizationofalbuminexcretionrate
AT ekincielifilhan longtermintraindividualvariabilityofalbuminuriaintype2diabetesmellitusimplicationsforcategorizationofalbuminexcretionrate
AT nguyencattram longtermintraindividualvariabilityofalbuminuriaintype2diabetesmellitusimplicationsforcategorizationofalbuminexcretionrate
AT milnemichele longtermintraindividualvariabilityofalbuminuriaintype2diabetesmellitusimplicationsforcategorizationofalbuminexcretionrate
AT hachemmariam longtermintraindividualvariabilityofalbuminuriaintype2diabetesmellitusimplicationsforcategorizationofalbuminexcretionrate
AT dobsonmatthew longtermintraindividualvariabilityofalbuminuriaintype2diabetesmellitusimplicationsforcategorizationofalbuminexcretionrate
AT macisaacrichardj longtermintraindividualvariabilityofalbuminuriaintype2diabetesmellitusimplicationsforcategorizationofalbuminexcretionrate
AT jerumsgeorge longtermintraindividualvariabilityofalbuminuriaintype2diabetesmellitusimplicationsforcategorizationofalbuminexcretionrate